Momentum Stocks: FireEye, Inc. (NASDAQ:FEYE), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Castlight Health, Inc. (NYSE:CSLT), Intevac Inc. (NASDAQ:IVAC), Sunshine Heart Inc. (NASDAQ:SSH)

FireEye, Inc. (NASDAQ:FEYE) belongs to Technology sector. Its weekly performance is 8.38%. On last trading day company shares ended up $45.01. FireEye, Inc. (NASDAQ:FEYE) distance from 50-day simple moving average (SMA50) is 7.69%. FireEye, Inc. (NASDAQ: FEYE) announced its intention to offer, subject to market conditions and other factors, $300.0 million aggregate principal amount of convertible senior notes due 2035 and $300.0 million aggregate principal amount of convertible senior notes due 2035 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares increased 2.15% in last trading session and ended the day at $130.62. ALNY return on assets is -13.60%. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) quarterly performance is 22.46%. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), announced that it has initiated a Phase 1 clinical trial with ALN-AS1, a subcutaneously administered investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 (ALAS1) for the treatment of acute hepatic porphyrias, including acute intermittent porphyria (AIP).

On 27 May, Castlight Health, Inc. (NYSE:CSLT) shares increased 1.92% and was closed at $9.03. Castlight Health, Inc. (NYSE:CSLT) year to date (YTD) performance is -22.82%. On May 21, 2015, Castlight Health, Inc. (NYSE:CSLT) and 150 Spear Street, LLC, a Delaware limited liability company (the “Landlord”) entered into that certain Office Lease (the “Lease”), under which the Company will lease approximately 36,000 square feet at 150 Spear Street, San Francisco, California, in order to expand the Company’s office facilities.

Intevac Inc. (NASDAQ:IVAC) ended the last trading day at $5.55. Company weekly volatility is calculated as 5.32% and price to cash ratio as 2.52. Intevac Inc. (NASDAQ:IVAC) showed a weekly performance of 4.91%. Benchmark Co. initiated coverage on shares of Intevac (NASDAQ:IVAC) in a research note released on Thursday morning. The firm issued a hold rating and a $6.00 target price on the stock.

Sunshine Heart Inc. (NASDAQ:SSH) shares increased 1.46% in last trading session and ended the day at $4.18. SSH return on assets is -64.70%. Sunshine Heart Inc. (NASDAQ:SSH) quarterly performance is -27.56%. Sunshine Heart Inc. (NASDAQ:SSH) has restarted its pivotal clinical trial and is speeding toward an early analysis that could lead to quicker approval for its implantable heart-failure therapy, the C-Pulse system.

Leave a Reply

Your email address will not be published. Required fields are marked *